Brief: Cstone Pharmaceuticals Was Informed By CEO That He Purchased 460,000 Shares In Open Market
26/06/2023 02:20
June 26 (Reuters) - CStone Pharmaceuticals 2616.HK :
* WAS INFORMED BY CEO THAT HE PURCHASED 460,000 SHARES IN
OPEN
MARKET ON JUNE 19 AND JUNE 20
* CEO TOTAL SHAREHOLDING INTEREST 3.58% OF TOTAL ISSUED
SHARE
CAPITAL OF CO
Source text for Eikon: ID:nHKS6f9mz9
Further company coverage: 2616.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026